SFDA-2023-0097-V197

Type II variation for application SFDA-2023-0097. Type II variation: Labeling Change for Thymosilib — major revision

Variation Number
SFDA-2023-0097-V197
Type
Type II
Application
SFDA-2023-0097
Change
CHG-2024-0197
Status
Approved
Fee
€12,204
Submitted
2023-01-13
Approved
2024-07-19
Description

Type II variation: Labeling Change for Thymosilib — major revision